Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hadji

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Current Medical Research and Opinion|January 19, 2010
Adherence and persistence in patients with severe osteoporosis treated with teriparatideV Ziller, S P Zimmermann, M Kalder, et al.
Zentralblatt Fur Gynakologie|September 20, 2001
[Scientific presentation using modern media]M Kalder, A Milkereit, U S Albert, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2011
Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone massP Hadji, D Gamerdinger, W Spieler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2016
Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort studyY Nestoriuc, P von Blanckenburg, F Schuricht, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 29, 2001
[Sonographic variability of lactating adenoma demonstrated by a longitudinal evaluation of 4 cases]K Bock, V F Duda, P Hadji, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 17, 2011
Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone massP Hadji, V Ziller, D Gamerdinger, et al.
Climacteric : the Journal of the International Menopause Society|November 7, 2002
Influence of pregnancy and breast-feeding on quantitative ultrasonometry of bone in postmenopausal womenP Hadji, V Ziller, M Kalder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Bone metastases in vulvar cancer: a rare metastatic patternF Fischer, M Kuhl, U Feek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancerP Hadji, M Blettner, N Harbeck, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Current Medical Research and Opinion|January 19, 2010
Adherence and persistence in patients with severe osteoporosis treated with teriparatideV Ziller, S P Zimmermann, M Kalder, et al.
Zentralblatt Fur Gynakologie|September 20, 2001
[Scientific presentation using modern media]M Kalder, A Milkereit, U S Albert, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2011
Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone massP Hadji, D Gamerdinger, W Spieler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2016
Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort studyY Nestoriuc, P von Blanckenburg, F Schuricht, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 29, 2001
[Sonographic variability of lactating adenoma demonstrated by a longitudinal evaluation of 4 cases]K Bock, V F Duda, P Hadji, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 17, 2011
Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone massP Hadji, V Ziller, D Gamerdinger, et al.
Climacteric : the Journal of the International Menopause Society|November 7, 2002
Influence of pregnancy and breast-feeding on quantitative ultrasonometry of bone in postmenopausal womenP Hadji, V Ziller, M Kalder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Bone metastases in vulvar cancer: a rare metastatic patternF Fischer, M Kuhl, U Feek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2013
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancerP Hadji, M Blettner, N Harbeck, et al.
Pageof 13